| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 51,048 | 61,853 | 55,515 | 56,878 |
| Short-term investments | 83,755 | 55,261 | 77,234 | 98,965 |
| Prepaid expenses and other current assets | 4,236 | 3,655 | 4,960 | 4,326 |
| Total current assets | 139,039 | 120,769 | 137,709 | 160,169 |
| Property and equipment, net | 47,606 | 50,026 | 53,715 | 56,649 |
| Operating lease right-of-use assets | 20,972 | 16,139 | 16,566 | 27,737 |
| Restricted cash | 2,359 | 2,359 | 2,314 | 2,709 |
| Long-term investments | 82,169 | NaN | NaN | 2,690 |
| Intangible assets | 34,200 | 34,200 | 34,200 | 34,200 |
| Security deposits and non-current assets | 208 | 211 | 213 | 538 |
| Total assets | 326,553 | 223,704 | 244,717 | 284,692 |
| Deposit liability | NaN | 20 | 20 | 20 |
| Accounts payable | 3,150 | 4,773 | 2,617 | 3,208 |
| Accrued expenses and other liabilities | 8,477 | 11,676 | 11,051 | 11,720 |
| Contingent consideration liability, short-term | 1,939 | 3,757 | 8,338 | NaN |
| Total current liabilities | 13,566 | 20,226 | 22,026 | 14,948 |
| Contingent consideration liability, long-term | NaN | NaN | 784 | 8,883 |
| Operating lease liability, long term | 43,942 | 40,241 | 41,185 | 46,589 |
| Deferred tax liability | 4,301 | 4,301 | 4,374 | 4,374 |
| Total liabilities | 61,809 | 64,768 | 68,369 | 74,794 |
| Common stock, 0.0001 par value, 300,000,000 shares authorized 180,102,343 and 87,519,096 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 18 | 9 | 9 | 9 |
| Additional paid-in capital | 1,078,873 | 950,814 | 949,015 | 948,124 |
| Accumulated deficit | -813,562 | -791,917 | -772,740 | -738,318 |
| Accumulated other comprehensive income | -585 | 30 | 64 | 83 |
| Total stockholders' equity | 264,744 | 158,936 | 176,348 | 209,898 |
| Total liabilities and stockholders' equity | 326,553 | 223,704 | 244,717 | 284,692 |
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)